ZOLL Medical Corporation Acquires Respicardia, Inc.

ZOLL Medical Corporation Acquires Itamar Medical Ltd.

December 16, 2021

Medical Devices

ZOLL Medical Corporation, an Asahi Kasei company, has completed the acquisition of Itamar Medical Ltd., a developer of at-home sleep apnea diagnostic devices and digital health solutions. ZOLL acquired all outstanding shares for $1.0333333 per ordinary share (approximately $31 per ADS), and Itamar will be delisted from Nasdaq and TASE and operate as a business division within ZOLL.

Resideo Technologies Acquires Snap One for $1.4B

April 15, 2024

Logistics & Distribution

Resideo Technologies agreed to acquire Snap One Holdings for $10.75 per share in cash, valuing the transaction at approximately $1.4 billion including net debt. Snap One will integrate into Resideo's ADI Global Distribution business to expand Resideo's smart-living product portfolio, proprietary offerings and distribution capabilities; the deal is financed in part by a $500 million perpetual convertible preferred equity investment from Clayton, Dubilier & Rice.

Picard Medical Acquires SynCardia Systems

September 30, 2021

Medical Devices

Picard Medical, a portfolio company of Hunniwell Lake Ventures, has acquired SynCardia Systems, the global leader in total artificial heart (TAH) technology. The deal brings SynCardia into Picard’s medical-device platform to accelerate product improvements, manufacturing capabilities, clinical support and pursuit of expanded regulatory approvals.

Kensington Capital Partners Acquires Resolute Health Corporation Limited

June 3, 2022

Healthcare Services

Kensington Capital Partners (Kensington) has acquired Resolute Health Corporation Limited, a Canada-based provider of obstructive sleep apnea (OSA) testing and treatment. Resolute operates a multi-brand network of clinics across several provinces; the partnership is intended to scale the business and expand geographic reach to provide greater access to OSA diagnosis and therapy.

Zeda Acquires The Orthopaedic Implant Company

February 13, 2024

Medical Devices

Zeda, Inc. has acquired The Orthopaedic Implant Company (OIC) to expand its medical device capabilities and broaden global manufacturing and distribution of value-based orthopaedic implants. OIC will operate as a Zeda Health company, combining OIC’s implant designs with Zeda’s advanced/additive manufacturing technologies to improve affordability and access to trauma and orthopaedic implants worldwide.

Cordis Acquires MedAlliance

October 17, 2022

Medical Devices

Cordis, the interventional cardiovascular device company, announced the acquisition of Switzerland-based MedAlliance, developer of the SELUTION SLR sirolimus drug‑eluting balloon. The deal includes an initial $35M investment, $200M payable at closing (expected 2023), plus up to $125M in regulatory milestones and up to $775M in commercial milestones through 2029; Cordis will begin co-promotion of SELUTION SLR in markets where it is available.